The associations of apolipoprotein e and angiotensin-converting enzyme polymorphisms and cognitive function in Type 1 diabetes based on an 18-year follow-up of the DCCT cohort

Diabetic Medicine

Volumn 27, Issue 1, 2010, Pages 15-22

  Jacobson, A M ^a   Paterson, A D ^b   Ryan, C M ^c   Cleary, P A ^d   Waberski, B H ^d   Weinger, K ^a   Musen, G ^a   Dahms, W ^e   Bayless, M ^f   Silvers, N ^g   Harth, J ^h   Boright, A P ⁱ  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d GEORGE WASHINGTON UNIVERSITY   (United States)

^e CASE WESTERN RESERVE UNIVERSITY   (United States)

^f UNIVERSITY OF IOWA   (United States)

^g UNIVERSITY OF PITTSBURGH   (United States)

^h WESTERN UNIVERSITY   (Canada)

ⁱ UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Angiotensin converting enzyme; Apolipoprotein E; Cognition; Genetics; Type 1 diabetes

Indexed keywords

APOLIPOPROTEIN E; DIPEPTIDYL CARBOXYPEPTIDASE; HEMOGLOBIN A1C;

ADULT; ARTICLE; CLINICAL ASSESSMENT; COGNITION; COGNITIVE DEFECT; COHORT ANALYSIS; COMA; FEMALE; FOLLOW UP; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPOGLYCEMIA; INDEL MUTATION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; POPULATION RESEARCH; SEIZURE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; APOLIPOPROTEINS E; COGNITION DISORDERS; DIABETES MELLITUS, TYPE 1; FEMALE; FOLLOW-UP STUDIES; GENETIC VARIATION; GENOTYPE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RISK FACTORS; YOUNG ADULT;

EID: 73949156939     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2009.02885.x     Document Type: Article

References (32)

1. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993 329 : 977 986.
2. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with Type 1 diabetes. N Engl J Med 2005 353 : 2643 2653.
3. Musen G, Lyoo IK, Sparks CR, Weinger K, Hwang J, Ryan CM et al. Effects of Type 1 diabetes on gray matter density as measured by voxel-based morphometry. Diabetes 2006 55 : 326 333.
4. Ryan CM. Diabetes and brain damage: more (or less) than meets the eye? Diabetologia 2006 49 : 2229 2233.
5. Savitz J, Solms M, Ramesar R. Apolipoprotein E variants and cognition in healthy individuals: a critical opinion. Brain Res Rev 2006 51 : 125 135.
6. Flory JD, Manuck SB, Ferrell RE, Ryan CM, Muldoon MF. Memory performance and the apolipoprotein E polymorphism in a community sample of middle-aged adults. Am J Med Genet (Neuropsychiatr Genet) 2000 96 : 707 711.
7. Parasuraman R, Greenwood PM, Sunderland T. The apolipoprotein E gene, attention, and brain function. Neuropsychology 2002 16 : 254 274.
8. Baxter LC, Caselli RJ, Johnson SC, Reiman E, Osborn D. Appolipoprotein E e4 affects new learning in cognitively normal individuals at risk for Alzheimer's disease. Neurobiol Aging 2003 24 : 947 952.
9. Small BJ, Rosnick CB, Fratiglioni L, Bäckman L. Apolipoprotein E and cognitive performance: a meta-analysis. Psychol Aging 2004 19 : 592 600.
10. Peila R, Rodriguez BL, Launer LJ. Type 2 diabetes, APOE gene and the risk for dementia and related pathologies: The Honolulu-Asia Study. Diabetes 2002 51 : 1256 1262.
11. Ferguson SC, Deary IJ, Evans JC, Ellard S, Hattersley AT, Frier BM. Apolipoprotein E influences aspects of intellectual ability in Type 1 diabetes. Diabetes 2003 52 : 145 148.
12. Jordan BD. Genetic influences on outcome following traumatic brian injury. Neurochem Res 2007 32 : 905 915.
13. Turic D, Fisher PJ, Plomin R, Owen MJ. No association betweeen apolipoprotein E polymorhphisms and general cognitive ability in children. Neurosci Lett 2001 299 : 97 100.
14. Shaw P, Lerch JP, Pruessner JC, Taylor KN, Rose AB, Greenstein D et al. Cortical morphology in children and adolescents with different apolipoprotein E gene polymorphisms: an observational study. Lancet Neurol 2007 6 : 494 500.
15. Wishart HA, Saykin AJ, McAllister TW, Rabin LA, McDonald BC, Flashman LA et al. Regional brain atrophy in cognitively intact adults with a single APOE e4 allele. Neurology 2006 67 : 1221 1224.
16. Bartrés-Faz D, Junqué C, Clemente IC, López-Alomar A, Valveny N, López-Guillén A et al. Angiotensin I converting enzyme polymorphism in humans with age-associated memory impairment: relationship with cognitive performance. Neurosci Lett 2000 290 : 177 180.
17. Richard F, Fromentin-David I, Ricolfi F, Ducimetière P, Di Menza C, Amouyel P et al. The angiotensin I converting enzyme gene as a susceptibility factor for dementia. Neurology 2001 56 : 1593 1595.
18. Visscher PM, Tynan M, Whiteman MC, Pattie A, White I, Hayward C et al. Lack of association between polymorphisms in angiotensin-converting-enzyme and methylenetretrahydrofolate reductase genes and normal cognitive aging in humans. Neurosci Lett 2003 347 : 175 178.
19. Stewart R, Powell J, Prince M, Mann A. ACE genotype and cognitive decline in an African-Carribean population. Neurobiol Aging 2004 25 : 1369 1375.
20. Savaskan E. The role of the brain rennin-angiotensin system in neurodegenerative disorders. Curr Alzheimer Res 2005 2 : 29 35.
21. Murdoch SJ, Boright AP, Paterson AD, Zinman B, Steffes M, Cleary P et al. LDL composition in E2/2 subjects and LDL distribution by Apo E genotype in Type 1 diabetes. Atherosclerosis 2007 192 : 138 147.
22. Al-Kateb H, Boright AP, Mirea L, Xie X, Sutradhar R, Mowjoodi A et al. Multiple superoxide disumutase 1/splicing factor serine alanine 15 variants are associated with the development and progression of diabetic nephropathy: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Genetics Study. Diabetes 2008 57 : 218 228.
23. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care 1999 22 : 99 111.
24. Diabetes Control and Complications Trial Research Group. Effects of intensive diabetes therapy on neuropsychological function in adults in the Diabetes Control and Complications Trial. Ann Intern Med 1996 124 : 379 388.
25. Lezak MD. Neuropsychological Assessment, 3rd edn. New York : Oxford University Press, 1995.
26. Boright AP, Paterson AD, Mirea L, Bull SB, Mowjoodi A, Scherer SW et al. Genetic variation at the ACE gene is associated with persistent microalbuminuria and severe nephropathy in Type 1 diabetes: the DCCT/EDIC Genetics Study. Diabetes 2005 54 : 1238 1244.
27. Amercian Diabetes Association. OLA Supplementary Dataset 3. Descriptive information of 1441 autosomal SNPs genotyped using illumina technology. 2007. Available at http://diabetes.diabetesjournals.org/content/57/1/218/suppl/DC1 Last accessed 10 December 2009.
28. Jacobson A, Ryan C, Cleary P, Waberski B, Burwood A, Weinger K et al. Long-term effect of diabetes and its treatment on cognitive function. N Engl J Med 2007 356 : 1842 1852.
29. Snedecor G, Cochran WG. Statistical methods - 8th edition. Ames, IA : Iowa State University Press, 1989.
30. Brands AMA, Biessels G-J, De Haan EHF, Kappelle LJ, Kessels RPC. The effects of Type 1 diabetes on cognitive performance: a meta-analysis. Diabetes Care 2005 28 : 726 735.
31. Peila R, White LR, Petrovich H, Masaki K, Ross GW, Havlik RJ et al. Joint effect of APOE gene and midlife systolic blood pressure on late-life cognitive impairment: The Honolulu-Asia Aging Study. Stroke 2001 32 : 2882 2889.
32. Louko A-M, Vilkki J, Niskakangas T. APOE genotype and cognition after subarachnoid haemorrhage: a longitudinal study. Acta Neurol Scand 2006 114 : 315 319.